CRISPR Therapeutics' stock decline is likely influenced by Editas ... Here's CRISPR’s last three-month chart: The market really seems to be punishing them over this time-period with really ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.